I-MAB (IMAB)
1.815
+0.02
(+1.40%)
USD |
NASDAQ |
May 07, 16:00
1.815
0.00 (0.00%)
After-Hours: 16:32
I-MAB SG&A Expense (Quarterly)
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 13.82M |
| September 30, 2020 | 20.13M |
| December 31, 2019 | 10.20M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.161M |
| December 31, 2018 | 3.685M |
| September 30, 2018 | 3.266M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.161M
Minimum
Sep 2019
20.13M
Maximum
Sep 2020
11.33M
Average
12.01M
Median
SG&A Expense (Quarterly) Benchmarks
| Zai Lab Ltd | 82.63M |
| WuXi Biologics (Cayman) Inc | -- |
| Wuxi AppTec Co Ltd | 105.51M |
| Gracell Biotechnologies Inc (DELISTED) | 4.381M |
| Sinovac Biotech Ltd | -- |